Company Research Report: Solventum

Company Overview

Name and Mission of the Company

Name: Solventum

Mission: Enabling better, smarter, safer healthcare to improve lives.

Founding and Key People

Founded: Previously known as 3M Health Care, Solventum has more than 70 years of delivering healthcare innovations.

Key People:

Bryan Hanson - Chief Executive Officer

Wayde McMillan - Chief Financial Officer

Sanjiv Arora - Chief Strategy & Corporate Development Officer

Chris Barry - Executive Vice President and Group President, Medical Surgical

Tammy Gomez - Chief Human Resources Officer

Paul Harrington - Chief Supply Chain Officer

Marcela Kirberger - Chief Legal Affairs Officer

Amy Landucci - Chief Information & Digital Officer

Headquarters

Location: No information is available on the specific headquarter location.

Workforce and Financials

Number of Employees: Approximately 22,000 professionals worldwide.

Revenue: $8.2 billion in sales in 2023.

Recognition

What the Company is Known For: Solventum is known for its legacy of creating breakthrough solutions at the intersection of health, material, and data science to transform patient experiences, improve outcomes, and help reduce total cost of care.

Products

Product Offerings

Solventum provides a wide range of products across several focus areas including:

Medical

Description: Solventum works with healthcare professionals to design solutions for better health outcomes and more efficient care.

Oral Care

Description: Offers advanced, clinically-proven solutions for dental care.

Health Information & Technology

Description: Provides strategic support for real-time, informed decisions in healthcare environments for efficiency and goal achievement.

Purification & Filtration

Description: Products aimed at helping innovations transition from lab to full-scale production efficiently.

Patients & Consumers

Description: Solutions that address everyday health needs with reputable brands.

Key Features

Solventum's solutions are known for their innovation and the ability to touch millions of lives while enhancing patient experience and saving time for healthcare professionals.

Recent Developments

New Products/Features:

Solventum launched an all-in-one, extended-wear wound dressing for V.A.C.® Therapy.

New Partnerships:

The company announced a sustainability commitment to 100% renewable electricity by 2030, highlighting its efforts in addressing climate change.

Leadership Changes

New Appointments:

Dr. Ryan Egeland, MD, appointed as Chief Medical Officer.

Financial News

Financial Results (Q3 2024):

Sales increased by 0.4% to $2.082 billion.

Generated $169 million in cash from operations.

Sustainability and Social Impact

Commitment to Sustainability: Solventum aims to use 100% renewable electricity across its operations by 2030.

This report captures the essential data about Solventum compiled from available information and presents a comprehensive view of the company's operations, leadership, products, and recent developments.